These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25966218)

  • 1. TGF-β1 polymorphism 509 C>T is associated with an increased risk for hepatocellular carcinoma in HCV-infected patients.
    Ma J; Liu YC; Fang Y; Cao Y; Liu ZL
    Genet Mol Res; 2015 May; 14(2):4461-8. PubMed ID: 25966218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients.
    Radwan MI; Pasha HF; Mohamed RH; Hussien HI; El-Khshab MN
    Cytokine; 2012 Oct; 60(1):271-6. PubMed ID: 22682513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between transforming growth factor-β1 -509 C>T variants and hepatocellular carcinoma susceptibility: a meta-analysis.
    Toshikuni N; Matsue Y; Minato T; Hayashi N; Tsutsumi M
    Neoplasma; 2016; 63(6):961-966. PubMed ID: 27596296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Chen YM; Wang H; Fang M; Ji Q; Zhao YP; Sun XJ; Liu Y; Gao CF
    Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.
    Nomair AM; Kandil LS; Nomeir HM; Kandil NS
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3317-3326. PubMed ID: 34711009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in the potential functional regions of the TGF-β 1 and TGF-β receptor genes and disease susceptibility in HBV-related hepatocellular carcinoma patients.
    Xin Z; Zhang W; Xu A; Zhang L; Yan T; Li Z; Wu X; Zhu X; Ma J; Li K; Li H; Liu Y
    Mol Carcinog; 2012 Oct; 51 Suppl 1():E123-31. PubMed ID: 22290546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of TGF-β1 and C-Kit Mutations in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients: in vitro Study.
    El-Houseini ME; Ismail A; Abdelaal AA; El-Habashy AH; Abdallah ZF; Mohamed MZ; El-Hadidi M; Cho WCS; Ahmed H; Al-Shafie TA
    Biochemistry (Mosc); 2019 Aug; 84(8):941-953. PubMed ID: 31522676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of transforming growth factor-beta1 gene polymorphisms with a hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
    Kim YJ; Lee HS; Im JP; Min BH; Kim HD; Jeong JB; Yoon JH; Kim CY; Kim MS; Kim JY; Jung JH; Kim LH; Park BL; Shin HD
    Exp Mol Med; 2003 Jun; 35(3):196-202. PubMed ID: 12858019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of IL-12B, IL-2, TGF-β1, and IL-4 polymorphism and expression on hepatitis B progression.
    Saxena R; Chawla YK; Verma I; Kaur J
    J Interferon Cytokine Res; 2014 Feb; 34(2):117-28. PubMed ID: 24161121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphism of interleukin-16 influences susceptibility to HBV-related hepatocellular carcinoma in a Chinese population.
    Li S; Deng Y; Chen ZP; Huang S; Liao XC; Lin LW; Li H; Peng T; Qin X; Zhao JM
    Infect Genet Evol; 2011 Dec; 11(8):2083-8. PubMed ID: 22019522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymorphisms and haplotypes of the TGF-β1 gene are associated with risk of polycystic ovary syndrome in Chinese Han women.
    Yang J; Zhong T; Xiao G; Chen Y; Liu J; Xia C; Du H; Kang X; Lin Y; Guan R; Yan P; Xiao J
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():1-7. PubMed ID: 25594618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-beta1 and C-erb-B2 neu oncoprotein in Egyptian HCV related chronic liver disease and hepatocellular carcinoma patients.
    El Bassuoni MA; Talaat RM; Ibrahim AA; Shaker OT
    Egypt J Immunol; 2008; 15(1):39-50. PubMed ID: 20306668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TGF-β1 -509C/T (or +869T/C) polymorphism might be not associated with hepatocellular carcinoma risk.
    Li W; Wu H; Song C
    Tumour Biol; 2013 Oct; 34(5):2675-81. PubMed ID: 23653379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma.
    Migita K; Miyazoe S; Maeda Y; Daikoku M; Abiru S; Ueki T; Yano K; Nagaoka S; Matsumoto T; Nakao K; Hamasaki K; Yatsuhashi H; Ishibashi H; Eguchi K
    J Hepatol; 2005 Apr; 42(4):505-10. PubMed ID: 15763337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of circulating Transforming growth factor-beta1, Glypican-3 and Golgi protein-73 mRNAs expression as predictive markers for hepatocellular carcinoma in Egyptian patients.
    Ibrahim GH; Mahmoud MA; Aly NM
    Mol Biol Rep; 2013 Dec; 40(12):7069-75. PubMed ID: 24186850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatitis C virus induced hepatocellular carcinoma associated genes].
    Kato N; Muroyama R; Goto K
    Nihon Rinsho; 2015 Feb; 73(2):333-8. PubMed ID: 25764692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The TGFB1 -509C/T polymorphism and elevated TGF-β1 levels are associated with chronic hepatitis C and cirrhosis.
    de Brito WB; Queiroz MAF; da Silva Graça Amoras E; Lima SS; da Silva Conde SRS; Dos Santos EJM; Cayres-Vallinoto IMV; Ishak R; Vallinoto ACR
    Immunobiology; 2020 Sep; 225(5):152002. PubMed ID: 32962821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming Growth Factor-β1 as a Predictor for the Development of Hepatocellular Carcinoma: A Nested Case-Controlled Study.
    Watanabe Y; Iwamura A; Shimada YJ; Wakai K; Tamakoshi A; Iso H;
    EBioMedicine; 2016 Oct; 12():68-71. PubMed ID: 27614396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer.
    Falleti E; Fabris C; Toniutto P; Fontanini E; Cussigh A; Bitetto D; Fornasiere E; Avellini C; Minisini R; Pirisi M
    Cytokine; 2008 Nov; 44(2):256-61. PubMed ID: 18809335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
    El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
    MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.